Curriculum

Breaking Down Metabolic Liver Disease: A Primary Care Approach To MASLD And MASH

This curriculum is designed to equip PCPs with a comprehensive understanding of MASLD and MASH, emphasizing key pathophysiologic mechanisms, cardiometabolic implications, and health consequences. In addition to the foundational 60-min. course, a 30-min. Podcast offers insights into a real patient’s experience and considers PCPs’ role in MASLD/MASH management and care pathway.

Loading... Begin

CME Information

1.50 AMA PRA Category 1 Credits™, 1.50 ABIM MOC or 1.42 AANP, 0.54 AANP Pharm

Available for credit until 7/23/2026

Topics

Faculty

Learning Objectives

  • Discuss the key pathophysiologic mechanisms, metabolic comorbidities, risk factors, and health consequences of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
  • Use noninvasive tools to screen, risk stratify, and guide treatment in patients with MASLD and MASH
  • Apply current guideline-directed management of MASLD and MASH, with a focus on risk factor reduction and management of comorbid cardiometabolic disease

Courses

1.50 CME/CE CREDITS

2 Courses

Downloadable Resources

 

 

Faculty Information

Vani Potluri, MD

Assistant Professor of Medicine, Section of General Internal Medicine, Baylor College of Medicine, Houston, Texas

Read More
Maddie J. Kubiliun, MD, MPH

Assistant Professor of Medicine, Division of Digestive and Liver Diseases, Associate Program Director | Internal Medicine Residency Program, University of Texas Southwestern Medical Center, Dallas, TX

Read More
Ivory Allison

National Senior Director of Community Impact, American Liver Foundation

Read More
Jeff Buckley (Patient)
Read More

Supported By

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Education Partners

Pri-Med Institute

American Liver Foundation